Loading clinical trials...
Loading clinical trials...
Risk Factors for Neck Phlegmon After Percutaneous Tracheostomy in ICU
Primary Purpose: To investigate the incidence and risk factors related to the appearance of tracheal phlegmon in patients undergoing percutaneous tracheostomy. Participant Population/Primary Condition: Patients admitted to Intensive Care Main Questions Aims to Answer: 1. \- What are the risk factors associated with the development of tracheal phlegmon percutaneous tracheostomy? 2. \- How does the appearance of tracheal phlegmon impact intensive care stay, hospital stay, mortality, and Health-related quality of life? Participants will be followed up after undergoing tracheostomy for 7 days to identify eventual phlegmons. At the two-year follow-up, the health-related quality of life will be assessed
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Maggiore Hospital Carlo Alberto Pizzardi
Bologna, Italy
Start Date
August 9, 2018
Primary Completion Date
December 31, 2024
Completion Date
January 31, 2025
Last Updated
August 14, 2024
300
ESTIMATED participants
Percutaneous tracheostomy
PROCEDURE
Lead Sponsor
Azienda Usl di Bologna
NCT07444697
NCT06819592
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions